IRWD Collar Strategy
IRWD (Ironwood Pharmaceuticals, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide.
IRWD (Ironwood Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $711.1M, a trailing P/E of 5.50, a beta of 0.21 versus the broader market, a 52-week range of 1.01-5.78, average daily share volume of 2.3M, a public-listing history dating back to 2010, approximately 100 full-time employees. These structural characteristics shape how IRWD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.21 indicates IRWD has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 5.50 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a collar on IRWD?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
IRWD snapshot
As of August 14, 2026, spot at $4.30, ATM IV 66.30%, IV rank 11.08%, expected move 19.01%. The collar on IRWD below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this collar structure on IRWD specifically: IV regime affects collar pricing on both sides; compressed IRWD IV at 66.30% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 19.01% (roughly $0.82 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IRWD expiries trade a higher absolute premium for lower per-day decay. Position sizing on IRWD should anchor to the underlying notional of $4.30 per share and to the trader's directional view on IRWD stock.
IRWD collar setup
The IRWD collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IRWD at $4.30 on that close, the first option leg uses a $4.52 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IRWD chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IRWD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $4.30 | long |
| Sell 1 | Call | $4.52 | N/A |
| Buy 1 | Put | $4.09 | N/A |
IRWD collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
IRWD collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on IRWD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on IRWD
Collars on IRWD hedge an existing long IRWD stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
IRWD thesis for this collar
The market-implied 1-standard-deviation range for IRWD extends from approximately $3.48 on the downside to $5.12 on the upside. A IRWD collar hedges an existing long IRWD position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current IRWD IV rank near 11.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IRWD at 66.30%. As a Healthcare name, IRWD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IRWD-specific events.
IRWD collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IRWD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IRWD alongside the broader basket even when IRWD-specific fundamentals are unchanged. Always rebuild the position from current IRWD chain quotes before placing a trade.
Frequently asked questions
- What is a collar on IRWD?
- A collar on IRWD is the collar strategy applied to IRWD (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With IRWD stock at $4.30 on the most recent close, the strikes shown on this page are snapped to the nearest listed IRWD chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are IRWD collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the IRWD collar priced from the end-of-day chain at a 30-day expiry (ATM IV 66.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IRWD collar?
- The breakeven for the IRWD collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The IRWD market-implied 1-standard-deviation expected move in the same options snapshot is approximately 19.01%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on IRWD?
- Collars on IRWD hedge an existing long IRWD stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current IRWD implied volatility affect this collar?
- IRWD ATM IV is at 66.30% with IV rank near 11.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.